← Leaderboards
Pooja Jain
Drexel University
$6,093,599
Attributed
$7,129,334
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $764.3K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,129,334 · 5
By mechanism
R01$5,539,059 · 3
R61$1,117,046 · 1
R56$473,229 · 1
Top collaborators
- Allison Michelle Andrews3 shared
- Servio Heybert Ramirez3 shared
- Brian Wigdahl2 shared
Most similar at Drexel University
Same institution · by research overlap
- Brian Wigdahl$23,790,183
- Zafar K Khan$424,510
- Michael R Nonnemacher$3,667,445
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsViralVirusVirus DiseasesSpinal Cord DiseasesTropical Spastic ParaparesisLinkHuman T-Lymphotropic Virus 1PlayPreventResponseInfectionTaxesT-LymphocyteEtiologyComplexInvestigationHiv-1MediatingNervous System DisorderPathogenesisCohortIn VivoImmune
Grant awards (20)
Innovative In-Situ Imaging Techniques for the Visualization of CNS associated HIV reservoirs in the Context of Substance Abuse$544,545
R61 · FY2025 · DA
Innovative In-Situ Imaging Techniques for the Visualization of CNS associated HIV reservoirs in the Context of Substance Abuse$572,500
R61 · FY2023 · DA
Innovative In-Situ Imaging Techniques for the Visualization of CNS associated HIV reservoirs in the Context of Substance Abuse$1
R61 · FY2023 · DA
Pre-clinical testing of a novel immunotherapy for HTLV-induced neurologic disease$431,433
R01 · FY2021 · NS · contact PI
Pre-clinical testing of a novel immunotherapy for HTLV-induced neurologic disease$431,433
R01 · FY2020 · NS · contact PI
Pre-clinical testing of a novel immunotherapy for HTLV-induced neurologic disease$431,433
R01 · FY2019 · NS · contact PI
Pre-clinical testing of a novel immunotherapy for HTLV-induced neurologic disease$431,433
R01 · FY2018 · NS · contact PI
Pre-clinical testing of a novel immunotherapy for HTLV-induced neurologic disease$459,683
R01 · FY2017 · NS · contact PI
HTLV-1 & Cellular Factors in Neuroinflammatory Disease$300,039
R01 · FY2016 · CA · contact PI
HTLV-1 & Cellular Factors in Neuroinflammatory Disease$29,450
R01 · FY2016 · CA · contact PI
HTLV-1 & Cellular Factors in Neuroinflammatory Disease$300,039
R01 · FY2015 · CA · contact PI
Restoring anti-viral immunity during HTLV-associated neuroinflammatory disease$473,229
R56 · FY2014 · AI · contact PI
HTLV-1 & Cellular Factors in Neuroinflammatory Disease$291,038
R01 · FY2014 · CA · contact PI
Define the role of dendritic cells in HTLV-1 associated neuroinflammatory disease$347,696
R01 · FY2013 · AI · contact PI
HTLV-1 & Cellular Factors in Neuroinflammatory Disease$282,037
R01 · FY2013 · CA
Define the role of dendritic cells in HTLV-1 associated neuroinflammatory disease$369,890
R01 · FY2012 · AI · contact PI
HTLV-1 & Cellular Factors in Neuroinflammatory Disease$300,039
R01 · FY2012 · CA
Define the role of dendritic cells in HTLV-1 associated neuroinflammatory disease$369,890
R01 · FY2011 · AI · contact PI
Define the role of dendritic cells in HTLV-1 associated neuroinflammatory disease$373,626
R01 · FY2010 · AI · contact PI
Define the role of dendritic cells in HTLV-1 associated neuroinflammatory disease$389,900
R01 · FY2009 · AI · contact PI